Neurology:神经科Aicardi-Goutières综合征患者的CT和MRI表现与基因型有关

2015-11-21 MedSci MedSci原创

研究扩展了AGS神经影像学表型的类别,为现有的经典的诊断标准提供了新依据。AGS患者神经影像学表型的异质性部分原因可以用AGS病程和AGS致病机制的复杂性解释。

加拿大麦吉尔大学蒙特利尔医院神经学研究所神经影像科Roberta La Piana和同事研究Aicardi-Goutieres综合征(一种罕见的幼年自体免疫疾病)患者的神经影像学模式和新图像扫描发现。研究结果2015年11月18日在Neurology在线发表

研究目的:研究AGS(Aicardi-Goutières syndrome,Aicardi-Goutières综合征)的神经影像学特点,并对相关文献予以更新。

方法:采集121例AGS患者的神经影像学数据。受试者行CT和MRI检查,系统分析AGS患者的CT和MRI数据。此外研究人员还评估了AGS患者的神经影像学表现、临床症状和基因型之间是否存在关联。

结果:共发现110例(90.9%)AGS患者存在脑部钙化灶。CT和MRI图像显示脑部存在较严重的钙化灶与AGS患者携带TREX1基因型、发病年龄较小有关。111例 (91.8%)受试者的CT和MRI图像显示存在脑萎缩。

受试者中有120例 (99.2%)儿童的CT和MRI图像提示脑部白质软化,主要分为3种类型:额颞叶白质软化、弥漫性白质软化和脑室周围白质软化。54例(50.0%)受试者的CT和MRI图像提示白质疏松,与AGS患者携带TREX1基因型、发病年龄较小有很强的关联性。

研究还发现了AGS患者的其他影像学新特点: AGS患者患病早期深部白质囊性变与AGS患者携带TREX1基因型有关联,髓鞘形成延迟与AGS患者携带RNASEH2B基因型有关。

结论:研究扩展了AGS神经影像学表型的类别,为现有的经典的诊断标准提供了新依据。AGS患者神经影像学表型的异质性部分原因可以用AGS病程和AGS致病机制的复杂性解释。

原始出处:

Roberta La Piana, Carla Uggetti, Federico Roncarolo, et all. Neuroradiologic patterns and novel imaging findings in Aicardi-Goutières syndrome. Neurology. Published online November 18,2015.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1890802, encodeId=849918908021d, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41717, encryptionId=742341e1782, topicName=基因型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 11 13:13:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105917, encodeId=dc3f10591e3e, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999604, encodeId=eba01999604f8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Mar 24 00:13:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634928, encodeId=8b03163492824, content=<a href='/topic/show?id=bc6d2166f3' target=_blank style='color:#2F92EE;'>#Aicardi-Goutières综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2166, encryptionId=bc6d2166f3, topicName=Aicardi-Goutières综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=521522344377, createdName=12498568m57暂无昵称, createdTime=Mon Jun 20 09:13:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430560, encodeId=75a514305602c, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443656, encodeId=5e09144365633, content=<a href='/topic/show?id=5b78e4414c7' target=_blank style='color:#2F92EE;'>#神经科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74414, encryptionId=5b78e4414c7, topicName=神经科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e5108341, createdName=12498f1em09(暂无昵称), createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1890802, encodeId=849918908021d, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41717, encryptionId=742341e1782, topicName=基因型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 11 13:13:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105917, encodeId=dc3f10591e3e, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999604, encodeId=eba01999604f8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Mar 24 00:13:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634928, encodeId=8b03163492824, content=<a href='/topic/show?id=bc6d2166f3' target=_blank style='color:#2F92EE;'>#Aicardi-Goutières综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2166, encryptionId=bc6d2166f3, topicName=Aicardi-Goutières综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=521522344377, createdName=12498568m57暂无昵称, createdTime=Mon Jun 20 09:13:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430560, encodeId=75a514305602c, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443656, encodeId=5e09144365633, content=<a href='/topic/show?id=5b78e4414c7' target=_blank style='color:#2F92EE;'>#神经科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74414, encryptionId=5b78e4414c7, topicName=神经科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e5108341, createdName=12498f1em09(暂无昵称), createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
    2016-08-27 李东泽

    这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1890802, encodeId=849918908021d, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41717, encryptionId=742341e1782, topicName=基因型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 11 13:13:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105917, encodeId=dc3f10591e3e, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999604, encodeId=eba01999604f8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Mar 24 00:13:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634928, encodeId=8b03163492824, content=<a href='/topic/show?id=bc6d2166f3' target=_blank style='color:#2F92EE;'>#Aicardi-Goutières综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2166, encryptionId=bc6d2166f3, topicName=Aicardi-Goutières综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=521522344377, createdName=12498568m57暂无昵称, createdTime=Mon Jun 20 09:13:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430560, encodeId=75a514305602c, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443656, encodeId=5e09144365633, content=<a href='/topic/show?id=5b78e4414c7' target=_blank style='color:#2F92EE;'>#神经科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74414, encryptionId=5b78e4414c7, topicName=神经科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e5108341, createdName=12498f1em09(暂无昵称), createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
    2016-03-24 yinhl1978
  4. [GetPortalCommentsPageByObjectIdResponse(id=1890802, encodeId=849918908021d, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41717, encryptionId=742341e1782, topicName=基因型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 11 13:13:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105917, encodeId=dc3f10591e3e, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999604, encodeId=eba01999604f8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Mar 24 00:13:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634928, encodeId=8b03163492824, content=<a href='/topic/show?id=bc6d2166f3' target=_blank style='color:#2F92EE;'>#Aicardi-Goutières综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2166, encryptionId=bc6d2166f3, topicName=Aicardi-Goutières综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=521522344377, createdName=12498568m57暂无昵称, createdTime=Mon Jun 20 09:13:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430560, encodeId=75a514305602c, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443656, encodeId=5e09144365633, content=<a href='/topic/show?id=5b78e4414c7' target=_blank style='color:#2F92EE;'>#神经科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74414, encryptionId=5b78e4414c7, topicName=神经科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e5108341, createdName=12498f1em09(暂无昵称), createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1890802, encodeId=849918908021d, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41717, encryptionId=742341e1782, topicName=基因型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 11 13:13:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105917, encodeId=dc3f10591e3e, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999604, encodeId=eba01999604f8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Mar 24 00:13:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634928, encodeId=8b03163492824, content=<a href='/topic/show?id=bc6d2166f3' target=_blank style='color:#2F92EE;'>#Aicardi-Goutières综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2166, encryptionId=bc6d2166f3, topicName=Aicardi-Goutières综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=521522344377, createdName=12498568m57暂无昵称, createdTime=Mon Jun 20 09:13:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430560, encodeId=75a514305602c, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443656, encodeId=5e09144365633, content=<a href='/topic/show?id=5b78e4414c7' target=_blank style='color:#2F92EE;'>#神经科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74414, encryptionId=5b78e4414c7, topicName=神经科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e5108341, createdName=12498f1em09(暂无昵称), createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1890802, encodeId=849918908021d, content=<a href='/topic/show?id=742341e1782' target=_blank style='color:#2F92EE;'>#基因型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41717, encryptionId=742341e1782, topicName=基因型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f984116, createdName=kzlchina, createdTime=Wed May 11 13:13:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105917, encodeId=dc3f10591e3e, content=这篇资讯带给我们新知识,启发新思维,不论是科研还是临床工作都有很大的帮助。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Aug 27 22:24:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999604, encodeId=eba01999604f8, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Thu Mar 24 00:13:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634928, encodeId=8b03163492824, content=<a href='/topic/show?id=bc6d2166f3' target=_blank style='color:#2F92EE;'>#Aicardi-Goutières综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2166, encryptionId=bc6d2166f3, topicName=Aicardi-Goutières综合征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=521522344377, createdName=12498568m57暂无昵称, createdTime=Mon Jun 20 09:13:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430560, encodeId=75a514305602c, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443656, encodeId=5e09144365633, content=<a href='/topic/show?id=5b78e4414c7' target=_blank style='color:#2F92EE;'>#神经科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74414, encryptionId=5b78e4414c7, topicName=神经科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a4e5108341, createdName=12498f1em09(暂无昵称), createdTime=Mon Nov 23 08:13:00 CST 2015, time=2015-11-23, status=1, ipAttribution=)]

相关资讯

FDA批准低剂量CT肺癌筛查方案用于高危人群的早期筛查

GE医疗近日宣布,该公司开发的低剂量计算机断层扫描(LDCT)肺癌筛查方案(LCS)获得美国FDA批准,这也是FDA批准用于肺癌高危群体筛查的首个低剂量CT解决方案。此次批准同时也标志着FDA首次批准将CT设备用于疾病的筛查。此前,美国预防服务工作组(USPSTF)和医疗保险及医疗补助服务中心(CMS)已推荐符合条件的人群每年进行低剂量CT筛查,同时低剂量CT应作为常规肺癌筛查项目。此外,美国Me

PLoS Med:胸部创伤,CT扫描区域可以减小

 在过去的二十年中,CT技术已经越来越多地用于成年人钝性创伤评价诊断,许多创伤中心采用常规的从头到骨盆的CT扫描。许多研究已经表明CT使用的延长和癌症风险有关。目前,许多专业机构已经呼吁对创伤CT诊断进行评价。对于有效的放射剂量,胸部CT的致癌风险相当大。此外,不必要的创伤胸部CT也可能会导致不必要的医疗花费。此前研究表明,在进行X光检查后进行胸部CT是一项低产出的事情,这导致了超过20

Thorax.:胸部CT上发现的肺囊肿——衰老还是临床意义?

目的:在一个以人群为基础的队列中探讨肺囊肿的发病率和自然病程,并描述CT图像特征与参与者的人口统计和肺功能的相关性。材料与方法:2633名受试者接受胸部CT扫描(平均年龄为59.2岁;50%是女性),这些受试者来自于Framingham心脏研究(FHS),在视觉上评估肺囊肿的存在和图像特征。这些研究结果与参与者的人口统计、肺功能检查的结果以及CT上独立检测到的肺气肿相关。通过与以前的CT扫描(平均

Thorax:高分辨率CT测量哮喘气道收缩和气道闭合,结果是更大的平行异质性

背景:非均匀性气道收缩和闭合是哮喘的特征。然而,到目前为止没有研究通过直接测量平行气道而获得图像数据,也就是说这一特征从来未被量化过,而且这些过程的解剖基础也仍不清楚。方法:7例正常受试者和9例哮喘受试者在予乙酰胆碱扩张气道的前后接受高分辨率的CT检查。分别测量28和24平行姐妹气道对(来自同一气道的分支,直径范围在1mm-8.7mm)的整个管腔的平均面积。非均匀性气道收缩被定义为是平行姐妹气道之

ERS 2015:CT随访有助于提高肺癌术后患者生存率

2015年欧洲呼吸学会大会在荷兰阿姆斯特丹召开,研究人员提出,如果肺癌复发患者接受后续胸部CT检查,则他们的术后生存率会得到进一步提高。这是第一个展示肺癌患者术后接受CT追踪随访可提高总生存期限的研究,并且有利于肺癌患者的预后,并提高其生存质量。 既往研究已经证实,对肺癌切除术后的患者随访过程中进行CT检查,大多数情况下都可在患者表现复发临床表现之前监测到复发的征兆。这有助于医生尽早确立诊断,采取